For immediate release
20 August 2013
MedicX Fund Limited
("MedicX Fund", "the Fund" or "the Company")
Issue of new ordinary shares
MedicX Fund Limited announces that earlier today it issued for cash, subject to admission, 3,000,000 new ordinary shares of no par value in the Company (the "New Shares"). The issue price per New Share (before expenses) was 77.5 pence. The New Shares were issued to satisfy general market demand.
Application has been made for the New Shares to be admitted to the premium segment of the Official List and to trading on the Main Market of the London Stock Exchange. It is expected that dealings in the New Shares will commence at 8.00 a.m. on 23 August 2013 ("Admission").
Total Voting Rights
In accordance with the Financial Conduct Authority's Disclosure and Transparency Rules, the total number of ordinary shares in the capital of the Company in issue on Admission will be 271,971,497 (excluding treasury shares) each with one voting right.
The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company, under the Disclosure and Transparency Rules.
The Company also holds 1,974,283 ordinary shares in treasury.
- End -
For further information please contact:
MedicX Group +44 (0) 1483 869 500
Keith Maddin, Chairman
Mike Adams, Chief Executive Officer
Mark Osmond, Chief Financial Officer
MedicX Fund Limited +44 (0) 1481 723 450
David Staples, Chairman
Canaccord Genuity Limited +44 (0) 20 7523 8000
Andrew Zychowski / Lucy Lewis
Buchanan Communications +44 (0) 20 7466 5000
Charles Ryland / Sophie McNulty
Information on MedicX Fund Limited
MedicX Fund Limited ("MXF", the "Fund" or the "Company", or together with its subsidiaries, the "Group") the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom, listed on the London Stock Exchange in November 2006. It has committed investment of £449.7 million and a portfolio of 122 properties.
The Investment Adviser to the Company is MedicX Adviser Ltd, which is authorised and regulated by the Financial Conduct Authority and is a subsidiary of the MedicX Group. The MedicX Group is a specialist investor, developer and manager of healthcare properties with 30 people operating across the UK.
The Company's website address is www.medicxfund.com. Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website), nor the contents of any website accessible from hyperlinks within this announcement, are incorporated into, or forms part of, this announcement.